Primary Use: Allergic rhinitis is a common upper respiratory problem seen routinely in clinical practice. This problem occurs when inhaled allergens come in contact with IgE antibodies on the surface of the airway triggering numerous acute symptoms: nasal congestion, sneezing, a watery ocular discharge, rhinnorea, and a pruritic palate along with sinus and eustachian tube congestion.
Vitamin C has been shown to decrease blood histamine levels. Vitamin C also raises glutathione levels by 50%. Increasing this potent antioxidant may help reduce nasal obstruction, rhinorrhea and ear fullness. A novel form of quercetin called EMIQ (enzymatically modified isoquercitrin) has been shown to reduce ocular allergic symptoms in those with pollinosis. EMIQ is prepared by using a natural enzyme process that attaches polysaccharides to convert quercetin into a soluble form. According to pharmacokinetic data, the absorption of EMIQ is up to 40 times greater (Cmax) and 15 times greater (AUC) than quercetin. The patented bioflavonoid pycnogenol, when given 5 weeks before birch allergy season, reduced eye and nasal symptoms by 35% and 19.5% respectively. Stinging nettle leaf has been shown in vitro to inhibit the pro-inflammatory pathways related to allergic rhinitis. Urtica is a potent 4:1 extract.
Serving Size: 2 capsules.
Amount Per Serving: Vitamin C ... 350mg (Calcium Ascorbate) Calcium ... 45mg (Calcium Ascorbate) Organic Spirulina ... 670mg (Spirulina platensis, whole) Stinging Nettle 4:1 Extract ... 100mg (Urtica dioica, leaf) Pycnogenol ... 34mg (French Maritime Pine Bark Extract [Pinus pinaster, stem bark]) EMIQ ... 33mg (Enzymatically Modified Isoquercitrin).
This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure or prevent any disease.
No comments:
Post a Comment